Skip to Main Content

Mercy Health Youngstown Medical Library
Jeghers Medical Index

Didactics Family Medicine

Delirium and Dementia Treatment


APACHE Acute Physiology and Chronic Health Evaluation -from ClinCalc

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.

Delirium DSM V critieria in UptoDate listed under Diagnosis of delirium and confusional states

Dementia DSM V criteria in UptoDate Evaluation of cognitive impairment and dementia

Inouye SK. Delirium in hospitalized older patients: recognition and risk factors. J Geriatr Psychiatry Neurol. 1998;11(3):118–125.

Inouye SK, Zhang Y, Jones RN, Kiely DK, Yang F, Marcantonio ER. Risk factors for delirium at discharge: development and validation of a predictive model. Arch Intern Med. 2007;167(13):1406–1413.

Witlox J, Eurelings LS, de Jonghe JF, et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA.2010;304(4):443–451.

Lee KH, Ha YC, Lee YK, Kang H, Koo KH. Frequency, risk factors, and prognosis of prolonged delirium in elderly patients after hip fracture surgery. Clin Orthop Relat Res. 2011;469(9):2612–2620.

Alici Y, Breitbart W. Delirium in palliative care. Prim Psychiatry. 2009;16(5):42–48.

Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006;35(4):350–364.

Shehabi Y, Riker RR, Bokesch PM, et al. SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group. Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. Crit Care Med. 2010;38(12):2311–2318.

American Family Physician 

Depression in the Elderly

Geriatrics and Pharmacology

. U.S. Census Bureau. The population 65 years and older in the United States: 2016. ACS-38. October 2018.
2. Hutchison LC. In: Hutchison LC, Sleeper RB ed. Fundamentals of geriatric pharmacotherapy. 2nd ed. Pp 57‐76
3. McLachlan AJ, Pont LG. Drug metabolism in older people--a key consideration in achieving optimal outcomes with medicines. J Gerontol A Biol Sci Med Sci. 2012 Feb;67(2):175-80. doi: 10.1093/gerona/glr118. Epub 2011 Aug 10. PMID: 21835808.
4.Hämmerlein, A et al. “Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.” Clinical pharmacokinetics vol. 35,1 (1998): 49-64. doi:10.2165/00003088-199835010-00004
5. By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. “American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults.” Journal of the American Geriatrics Society vol. 67,4 (2019): 674-694. doi:10.1111/jgs.15767.
6. Steinman MA and Fick DM. Using Wisely: A Reminder on the Proper Use of the American Geriatrics Society Beers Criteria. J Am Geriatr Soc. 2019 April;67(4):644-646. 
7. Holmes H, et al. Arch Intern Med. 2006; 166:605‐9.

American Geriatrics Society Updated Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults

Neurocognitive Disorders

Parkinson's Disease

Resources for the Elderly